Abony: “Pluri’s cell expansion technology has extraordinary potential across a range of industries.” Mr. Lorne Abony Mr. Lorne Abony HAIFA, Israel, July 13, 2023 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote wellbeing and sustainability, today announced the appointment of Lorne Abony to the Company’s Board of Directors, effective as of July 11, 2023. Abony is a successful entrepre
Related Keywords
Israel , Shachar Yental , Yaky Yanay , Lorne Abony , Zami Aberman , Meira Feinman , Twitter , Nasdaq , Technology Ltd , Linkedin , Vitrolabs Inc , Pluri Inc , Company Board Of Directors , Nuuvera Inc , Mood Media Corporation , Emmac Life Sciences , Exchange Commission , Pluri Chairman , Emmac Life Sciences Limited , Young Entrepreneur , Year Award , Private Securities Litigation Reform Act , Investor Relations , Aviva Banczewski , Nathan Miller , Luri Inc , Well Expansion , Biotech Company , The Company , Technology ,
comparemela.com © 2020. All Rights Reserved.